Maravai climbs on collaboration to launch DNA concentration testing kit

Maravai Lifesciences Holdings

28/08/2024 15:13

(Updates)
    ** Shares of diagnostics co Maravai LifeSciences  MRVI.O 
rise ~1.1% to $9.13 
    ** Co says Cygnus Technologies and TriLink BioTechnologies,
both part of Maravai, have collaborated to launch AccuRes host
cell DNA quantification kits
    ** The kits determine concentration of DNA in a sample and
help to produce safe and stable vaccines and therapies 
    ** Including session's move, stock up 38% YTD

    

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))